Fading Vertex Pharmaceuticals (CA) Drug Incivek was Also Fastest to Become a Blockbuster

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

How is this for irony? The same week that Vertex Pharmaceuticals (VRTX) cuts 15 percent of its workforce due to plunging sales of its Incivek treatment for hepatitis C, the drug has been identified as having achieved blockbuster status faster than any other medicine. Incivek was launched in 2011, by the way, and surpassed Celebrex, which is sold by Pfizer (PFE) but was launched in 1999 by Pharmacia.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news